exenatide, an experimental new drug for type 2 diabetes

July 2004

There's excitement about exenatide, an experimental new drug for type 2 diabetes.

It's made from the saliva of the Gila monster.

It's the first in a new class called incretin mimetics.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

statins might have benefits beyond preventing heart attacks and strokes
Allergic Reactions whether patients who are allergic to sulfonamides can take Celebrex or Bextra
Renal & Urology DAILY Viagra to help restore erectile function after prostate surgery
Dermatology OTC scar products
Diabetes exenatide, an experimental new drug for type 2 diabetes
Infectious Diseases new antibiotic for traveler's diarrhea called Xifaxan (zuh-FAX-in, rifaximin)
Infectious Diseases new antiprotozoal drug called Tindamax (tinidazole)
Infectious Diseases Hepatitis C treatments don't seem to work as well in African Americans
Cardiology Is it safe to give an angiotensin receptor blocker (ARB) to patients who have had angioedema while taking an ACE inhibitor
Cardiology drugs that can cause orthostatic hypotension
lots of ads for "low-carb" vitamins
Coenzyme Q10 is beneficial for some conditions
Women's Health Menostar, the lowest-dose estrogen patch
Women's Health hepatotoxicity with black cohosh
drug company funding for drug trials is leading to biased findings and inappropriate prescribing